Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Fructose Consumption is Associated with Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study from Iran

Mina Darand 1 , Zahra Darabi 1 , Zahra Yari 1 and Azita Hekmatdoost 1 , *
Authors Information
1 Department of Clinical Nutrition, Faculty of Nutrition, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Hepatitis Monthly: 19 (4); e88283
  • Published Online: May 1, 2019
  • Article Type: Research Article
  • Received: December 25, 2018
  • Revised: March 7, 2019
  • Accepted: April 15, 2019
  • DOI: 10.5812/hepatmon.88283

To Cite: Darand M, Darabi Z, Yari Z, Hekmatdoost A. Fructose Consumption is Associated with Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study from Iran, Hepat Mon. Online ahead of Print ; 19(4):e88283. doi: 10.5812/hepatmon.88283.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA. 2015;313(22):2263-73. doi: 10.1001/jama.2015.5370. [PubMed: 26057287].
  • 2. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155-61. doi: 10.1159/000282080. [PubMed: 20460905].
  • 3. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20. doi: 10.1038/nrgastro.2017.109. [PubMed: 28930295].
  • 4. Younossi ZM, Henry L. Economic and quality-of-life implications of non-alcoholic fatty liver disease. Pharmacoeconomics. 2015;33(12):1245-53. doi: 10.1007/s40273-015-0316-5. [PubMed: 26233836].
  • 5. Ghaemi A, Taleban FA, Hekmatdoost A, Rafiei A, Hosseini V, Amiri Z, et al. How much weight loss is effective on nonalcoholic fatty liver disease? Hepat Mon. 2013;13(12). e15227. doi: 10.5812/hepatmon.15227. [PubMed: 24358045]. [PubMed Central: PMC3867211].
  • 6. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251-64. doi: 10.1038/nrgastro.2010.41. [PubMed: 20368739].
  • 7. Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Synbiotic supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99(3):535-42. doi: 10.3945/ajcn.113.068890. [PubMed: 24401715].
  • 8. Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA. Ginger supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. Hepat Mon. 2016;16(1). e34897. doi: 10.5812/hepatmon.34897. [PubMed: 27110262]. [PubMed Central: PMC4834197].
  • 9. Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study. Int J Food Sci Nutr. 2016;67(4):461-9. doi: 10.3109/09637486.2016.1161011. [PubMed: 26983396].
  • 10. Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100(6):2434-42. doi: 10.1210/jc.2014-3678. [PubMed: 25825943]. [PubMed Central: PMC4454806].
  • 11. Zhang DM, Jiao RQ, Kong LD. High dietary fructose: Direct or indirect dangerous factors disturbing tissue and organ functions. Nutrients. 2017;9(4). doi: 10.3390/nu9040335. [PubMed: 28353649]. [PubMed Central: PMC5409674].
  • 12. Jegatheesan P, De Bandt JP. Fructose and NAFLD: The multifaceted aspects of fructose metabolism. Nutrients. 2017;9(3). doi: 10.3390/nu9030230. [PubMed: 28273805]. [PubMed Central: PMC5372893].
  • 13. Chiu S, Sievenpiper JL, de Souza RJ, Cozma AI, Mirrahimi A, Carleton AJ, et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68(4):416-23. doi: 10.1038/ejcn.2014.8. [PubMed: 24569542]. [PubMed Central: PMC3975811].
  • 14. Alwahsh SM, Gebhardt R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch Toxicol. 2017;91(4):1545-63. doi: 10.1007/s00204-016-1892-7. [PubMed: 27995280].
  • 15. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48(6):993-9. doi: 10.1016/j.jhep.2008.02.011. [PubMed: 18395287]. [PubMed Central: PMC2423467].
  • 16. Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 2016;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. [PubMed: 27436528].
  • 17. Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A. Egg consumption and risk of non-alcoholic fatty liver disease. World J Hepatol. 2017;9(10):503-9. doi: 10.4254/wjh.v9.i10.503. [PubMed: 28443155]. [PubMed Central: PMC5387362].
  • 18. FAO . Dietary assessment: A resource guide to method selection and application in low resource settings. Rome: Food and Agriculture Organization of the United Nations; 2018.
  • 19. Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20(2):150-8. doi: 10.2188/jea.JE20090083. [PubMed: 20154450]. [PubMed Central: PMC3900814].
  • 20. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654-62. doi: 10.1017/S1368980009991698. [PubMed: 19807937].
  • 21. Food and Nutrition Information Center. Composition of foods raw, processed, prepared USDA national nutrient database for standard reference, release 27 documentation and user guide. Beltsville, Maryland: US Department of Agriculture: Food composition table (FCT); 2009.
  • 22. Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063-75. doi: 10.1016/j.jhep.2018.01.019. [PubMed: 29408694]. [PubMed Central: PMC5893377].
  • 23. Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2015;4(2):109-16. doi: 10.3978/j.issn.2304-3881.2014.11.05. [PubMed: 26005677]. [PubMed Central: PMC4405421].
  • 24. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(6):1961-71. doi: 10.1002/hep.23535. [PubMed: 20301112]. [PubMed Central: PMC2922495].
  • 25. Nier A, Brandt A, Conzelmann IB, Ozel Y, Bergheim I. Non-alcoholic fatty liver disease in overweight children: Role of fructose intake and dietary pattern. Nutrients. 2018;10(9). doi: 10.3390/nu10091329. [PubMed: 30235828]. [PubMed Central: PMC6165138].
  • 26. Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, et al. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 2014;6(8):3187-201. doi: 10.3390/nu6083187. [PubMed: 25111123]. [PubMed Central: PMC4145302].
  • 27. Kanerva N, Sandboge S, Kaartinen NE, Mannisto S, Eriksson JG. Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr. 2014;100(4):1133-8. doi: 10.3945/ajcn.114.086074. [PubMed: 25099548].
  • 28. Saadati S, Hekmatdoost A, Hatami B, Mansour A, Zahra Z, Hedayati M, et al. Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease. Gastroenterol Hepatol Bed Bench. 2018;11(Suppl 1):S8-S13. [PubMed: 30774801]. [PubMed Central: PMC6347983].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments